KVK-Tech Recalls Benzphetamine Tablets Due to Discoloration
KVK-Tech recalls specific lots of 50 mg Benzphetamine tablets due to scuffing marks and discoloration. Check your bottle's lot number.
Recall notice
Discoloration: presence of scuffing marks on tablets.
Contact the company
What happened, in plain English
KVK-Tech, Inc. is recalling Benzphetamine Hydrochloride Tablets, 50 mg, in 30-count bottles due to discoloration and scuffing marks on the tablets. The recall affects specific lots distributed nationwide. No remedy or health risk details are provided in the record. Read more at govinfonow.com/recall/42845-kvk-tech-recalls-benzphetamine-tablets-due-to-discoloration.
Source Summary by GovInfoNow · govinfonow.com/recall/42845-kvk-tech-recalls-benzphetamine-tablets-due-to-discoloration · Updated October 9, 2026 · FDA enforcement record: FDA #D-1057-2016
Cite this page
“KVK-Tech Recalls Benzphetamine Tablets Due to Discoloration.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42845-kvk-tech-recalls-benzphetamine-tablets-due-to-discoloration. Based on FDA recall #D-1057-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1057-2016%22&limit=1).
Why it’s dangerous
The record states that the hazard is the presence of scuffing marks on the tablets, resulting in discoloration. It does not explain what this defect means for the drug's safety, efficacy, or potential side effects.
Who’s affected
Consumers who purchased Benzphetamine Hydrochloride Tablets, 50 mg, from pharmacies across the United States between unspecified dates and with expiration dates of August 2018. The record does not specify which health conditions these tablets treat or who is most at risk.
How to tell if you have this one
Check your medication bottle for the following details: Manufacturer KVK-Tech, Inc.; NDC 10702-0040-03; Lot numbers 12825A or 12937A; and an expiration date of 8/18. The tablets are 50 mg, RX only, in a 30-count bottle.
- Brand
KVK-Tech- Category
Drug
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1057-2016 (May 5, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1057-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.